Search bioRxiv⌕ Search

Biology subjects

Roy, S. M.

Publications and source records attributed to Roy, S. M..

2 recordsLinked to original sources

Characterizing Individual and Population-Level Heterogeneity in Infant BMI Trajectories Using Flexible and Functional Modeling Approaches

Infant body mass index (BMI) follows a rapid and nonlinear trajectory, yet substantial inter-individual variation complicates accurate characterization of growth dynamics. Here we systematically compared individual- and group-based approaches for modeling longitudinal BMI trajectories in 2,114 healthy infants. Among linear spline, natural cubic spline and fractional polynomial mixed-effects models and SITAR, natural cubic splines provided the best fit while preserving individual variation in trajectory shape. Across all models, males reached their BMI peak earlier than females. To characterize population-level heterogeneity, we further compared latent class mixed models with functional principal component analysis (FPCA) followed by Gaussian mixture clustering. Whereas latent class modeling produced numerous small classes, FPCA identified three interpretable trajectory groups in both sexes, including a rare subgroup characterized by higher BMI and delayed or unestimable peak timing. Maternal gestational diabetes was associated with earlier BMI peak timing in females and was enriched in the rare female trajectory subgroup. Together, these results support combining flexible mixed-effects modeling with functional trajectory analysis to characterize both individual growth dynamics and population-level heterogeneity during infancy.

developmental biology↗

The Highly Selective 5-HT2B Receptor Antagonist MW073 Mitigates Aggressive Behavior in an Alzheimer Disease Mouse Model.

1.Alzheimers disease (AD) is a multifactorial neurodegenerative disorder and the leading cause of dementia worldwide. Progressive synaptic and neuronal loss underlies the decline in cognition and daily functioning, often accompanied by behavioral and psychological symptoms. Among these, neuropsychiatric disturbances such as agitation and aggression affect 20-65% of patients and represent a major source of caregiver burden. The serotonin receptor antagonist MW073 has recently emerged as a potential therapeutic candidate, showing efficacy in counteracting A{beta}- and tau-induced synaptic and memory deficits in AD mouse models. Here, we investigated whether MW073 also mitigates aggressive behavior in Tg2576 mice, a widely used AD model that also displays heightened aggressiveness. Our findings demonstrate that MW073 significantly reduced aggressive tendencies in Tg2576 mice, suggesting that serotonergic modulation may represent a promising strategy to address both cognitive and neuropsychiatric symptoms of AD.

neuroscience↗